PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F15FF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $184,033
Award facts
- Contract value 100% obligated
- $184,032.52 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $184,032.52, was awarded on January 24, 2026, to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3), a subsidiary of Cencora, Inc., for pharmaceutical and medical supply products to be delivered to Conshohocken, Pennsylvania. The contract features firm fixed-price pricing with an ultimate completion date of January 26, 2026, and was awarded without set-aside designations through competitive procurement. The award is structured as a delivery order under a larger Indefinite Delivery Contract vehicle with the Defense Logistics Agency (DLA) Troop Support Medical, which carries a potential value of $999,999,999.00 through December 2026. This IDC serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply an extensive range of pharmaceutical products, medical supplies, vaccines, and specialized healthcare commodities to support military healthcare programs worldwide.
The funding originates from the Defense Logistics Agency's Medical Supply Chain division, which relies on AmerisourceBergen's extensive pharmaceutical distribution capabilities to serve critical federal healthcare needs, including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. AmerisourceBergen's demonstrated competitiveness in open competition and its ability to manage substantial delivery volumes across multiple therapeutic domains—ranging from specialty medications to generic drugs—position it as a key vendor for federal medical procurement. The parent company, Cencora, Inc., maintains additional Indefinite Delivery Contracts with the DLA valued at up to $999,999,999.00 through December 31, 2031, further establishing the company's critical role in the federal pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2D826F15FF?
SPE2D826F15FF was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 24, 2026.
How much is contract SPE2D826F15FF worth?
The government has obligated $184,033 on SPE2D826F15FF.
Is contract SPE2D826F15FF an order under another contract?
Yes. SPE2D826F15FF is a delivery order under SPE2DX22D0020, an indefinite delivery contract.
Was contract SPE2D826F15FF competed?
The extent of competition for SPE2D826F15FF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award